Skip to main content

Advertisement

Log in

Role of serine protease inhibitor, ulinastatin, in rat model of hepatic encephalopathy: aquaporin 4 molecular targeting and therapeutic implication

  • Original Article
  • Published:
Journal of Physiology and Biochemistry Aims and scope Submit manuscript

Abstract

Hepatic encephalopathy (HE) is a devastating neuropsychiatric presentation of the advanced hepatic insufficiency. It is associated with high morbidity and mortality. Aquaporin-4 (AQP4), the principal astrocyte water channel, is primarily involved in brain edema development. Ulinastatin (ULI) is a potent protease inhibitor, extracted from fresh human urine. We hypothesized that ULI could be neuroprotective in acute HE through molecular targeting of brain AQP4, which is known to be upregulated in HE. To induce acute liver failure (ALF), the rats were acutely intoxicated with thioacetamide (TAA). Animals were randomized into HE- and ULI-treated HE groups, with control normal group. Total bilirubin, albumin, serum aminotransferases, and serum/brain ammonia/proinflammatory cytokines, blood–brain barrier (BBB) integrity/tight junction proteins, brain water content, and neurological scores were assessed. Additionally, brain AQP4 and α-Syntrophin mRNA expression and protein levels were evaluated by quantitative real-time PCR and enzyme-linked immunosorbent assay, respectively. Brain and liver tissues were stripped and processed for further microscopic and histological analyses. ULI exerted potent dual neuro/hepato protective potential, improved neurological score, animals’ survival, ameliorated brain edema, probably via anti-inflammatory activity, preserved BBB integrity, down-regulated AQP4 expression, and membrane polarization by decreased α-syntrophin level, with rescued brain bioenergetics. ULI could be tooled as a possible therapeutic option in HE in ALF.

Graphical abstract

The possible ULI mediated protection in TAA-induced HE rat model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Adeva MM, Souto G, Blanco N, Donapetry C (2012) Ammonium metabolism in humans. Metabolism 61:1495–1511

    CAS  PubMed  Google Scholar 

  2. Anderova M, Benesova J, Mikesova M, Dzamba D, Honsa P, Kriska J, Butenko O, Novosadova V, Valihrach L, Kubista M, Dmytrenko L, Cicanic M, Vargova L (2014) Altered astrocytic swelling in the cortex of α-syntrophin-negative GFAP/EGFP mice. PLoS One 9:e113444

    PubMed  PubMed Central  Google Scholar 

  3. Assentoft M, Kaptan S, Schneider HP, Deitmer JW, de Groot BL, MacAulay N (2016) Aquaporin 4 as a NH3 channel. J Biol Chem 291:19184–19195

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Avraham Y, Grigoriadis N, Poutahidis T, Vorobiev L, Magen I, Ilan Y, Mechoulam R, Berry E (2011) Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice. Br J Pharmacol 162:1650–1658

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Benarroch EE (2007) Aquaporin-4, homeostasis, and neurologic disease. Neurology 69:2266–2268

    PubMed  Google Scholar 

  6. Bobermin LD, Hansel G, Scherer EB, Wyse AT, Souza DO, Quincozes-Santos A, Gonçalves CA (2015) Ammonia impairs glutamatergic communication in astroglial cells: protective role of resveratrol. Toxicol in Vitro 29:2022–2029

    CAS  PubMed  Google Scholar 

  7. Bodega G, Suárez I, López-Fernández LA, García MI, Köber M, Penedo M, Luna M, Juárez S, Ciordia S, Oria M, Córdoba J, Fernández B (2012) Ammonia induces aquaporin-4 rearrangement in the plasma membrane of cultured astrocytes. Neurochem Int 61:1314–1324

    CAS  PubMed  Google Scholar 

  8. Butterworth RF (2010) Altered glial-neuronal crosstalk: cornerstone in the pathogenesis of hepatic encephalopathy. Neurochem Int 57:383–388

    CAS  PubMed  Google Scholar 

  9. Butterworth RF (2015) Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure. J Clin Exp Hepatol 5:S96–S103

    PubMed  Google Scholar 

  10. Chen HM, Huang HS, Ruan L, He YB, Li XJ (2014) Ulinastatin attenuates cerebral ischemia-reperfusion injury in rats. Int J Clin Exp Med 7:1483–1489

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Chu H, Huang C, Ding H, Dong J, Gao Z, Yang X, Tang Y, Dong Q (2016) Aquaporin-4 and cerebrovascular diseases. Int J Mol Sci 17

  12. Cui T, Zhu G (2015) Ulinastatin attenuates brain edema after traumatic brain injury in rats. Cell Biochem Biophys 71:595–600

    CAS  PubMed  Google Scholar 

  13. Dai H, Song D, Xu J, Li B, Hertz L, Peng L (2013) Ammonia-induced Na,K-ATPase/ouabain-mediated EGF receptor transactivation, MAPK/ERK and PI3K/AKT signaling and ROS formation cause astrocyte swelling. Neurochem Int 63:610–625

    CAS  PubMed  Google Scholar 

  14. Esmann M (1988) ATPase and phosphatase activity of Na+,K+-ATPase: molar and specific activity, protein determination. Methods Enzymol 156:105–115

    CAS  PubMed  Google Scholar 

  15. Fang M, Zhong WH, Song WL, Deng YY, Yang DM, Xiong B, Zeng HK, Wang HD (2018) Ulinastatin ameliorates pulmonary capillary endothelial permeability induced by sepsis through protection of tight junctions via inhibition of TNF-α and related pathways. Front Pharmacol 9:823

    PubMed  PubMed Central  Google Scholar 

  16. Farjam M, Dehdab P, Abbassnia F, Mehrabani D, Tanideh N, Pakbaz S, Imanieh MH (2012) Thioacetamide-induced acute hepatic encephalopathy in rat: behavioral, biochemical and histological changes. Iran Red Crescent Med J 14:164–170

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Fukuda AM, Badaut J (2012) Aquaporin 4: a player in cerebral edema and neuroinflammation. J Neuroinflammation 9:279

    CAS  PubMed  PubMed Central  Google Scholar 

  18. He W, Liu Y, Geng H, Li Y (2015) The regulation effect of ulinastatin on the expression of SSAT2 and AQP4 in myocardial tissue of rats after cardiopulmonary resuscitation. Int J Clin Exp Pathol 8:10792–10799

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Heidari R (2019) Brain mitochondria as potential therapeutic targets for managing hepatic encephalopathy. Life Sci 218:65–80

    CAS  PubMed  Google Scholar 

  20. Heidari R, Jamshidzadeh A, Ghanbarinejad V, Ommati MM, Niknahad H (2018) Taurine supplementation abates cirrhosis-associated locomotor dysfunction. Clin Exp Hepatol 4:72–82

    PubMed  PubMed Central  Google Scholar 

  21. Huang Y, Li SN, Zhou XY, Zhang LX, Chen GX, Wang TH, Xia QJ, Liang N, Zhang X (2019) The dual role of AQP4 in cytotoxic and vasogenic edema following spinal cord contusion and its possible association with energy metabolism via COX5A. Front Neurosci 13:584

    PubMed  PubMed Central  Google Scholar 

  22. Inoue K, Takano H (2010) Urinary trypsin inhibitor as a therapeutic option for endotoxin-related inflammatory disorders. Expert Opin Investig Drugs 19:513–520

    CAS  PubMed  Google Scholar 

  23. Ito H, Yamamoto N, Arima H, Hirate H, Morishima T, Umenishi F, Tada T, Asai K, Katsuya H, Sobue K (2006) Interleukin-1beta induces the expression of aquaporin-4 through a nuclear factor-kappaB pathway in rat astrocytes. J Neurochem 99:107–118

    CAS  PubMed  Google Scholar 

  24. Jamshidzadeh A, Heidari R, Abasvali M, Zarei M, Ommati MM, Abdoli N, Khodaei F, Yeganeh Y, Jafari F, Zarei A, Latifpour Z, Mardani E, Azarpira N, Asadi B, Najibi A (2017) Taurine treatment preserves brain and liver mitochondrial function in a rat model of fulminant hepatic failure and hyperammonemia. Biomed Pharmacother 86:514–520

    CAS  PubMed  Google Scholar 

  25. Ju M, He H, Chen S, Liu Y, Liu Y, Pan S, Zheng Y, Xuan L, Zhu D, Luo Z (2019) Ulinastatin ameliorates LPS-induced pulmonary inflammation and injury by blocking the MAPK/NF-κB signaling pathways in rats. Mol Med Rep 20:3347–3354

    CAS  PubMed  Google Scholar 

  26. Karnad DR, Bhadade R, Verma PK, Moulick ND, Daga MK, Chafekar ND, Iyer S (2014) Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study. Intensive Care Med 40:830–838

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Kelly T, Rose CR (2010) Ammonium influx pathways into astrocytes and neurones of hippocampal slices. J Neurochem 115:1123–1136

    CAS  PubMed  Google Scholar 

  28. Liere V, Sandhu G, DeMorrow S (2017) Recent advances in hepatic encephalopathy. F1000Res 6:1637

    PubMed  PubMed Central  Google Scholar 

  29. Lippi U, Guidi G (1970) A new colorimetric ultramicromethod for serum glutamic-oxalacetic and glutamic pyruvic transaminase determination. Clin Chim Acta 28:431–437

    CAS  PubMed  Google Scholar 

  30. Llansola M, Montoliu C, Agusti A, Hernandez-Rabaza V, Cabrera-Pastor A, Gomez-Gimenez B, Malaguarnera M, Dadsetan S, Belghiti M, Garcia-Garcia R, Balzano T, Taoro L, Felipo V (2015) Interplay between glutamatergic and GABAergic neurotransmission alterations in cognitive and motor impairment in minimal hepatic encephalopathy. Neurochem Int 88:15–19

    CAS  PubMed  Google Scholar 

  31. Lu J, Chen YP, Wan R, Guo CY, Wang XP (2012) Protective effects of ulinastatin on acute liver failure induced by lipopolysaccharide/D-galactosamine. Dig Dis Sci 57:399–404

    CAS  PubMed  Google Scholar 

  32. Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, Chan P, Verkman AS (2000) Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 6:159–163

    CAS  PubMed  Google Scholar 

  33. Mao J, Zhang L, Song AL, Chen X, Zhang YC (2011) Effect of ulinastatin donor-pretreatment on liver graft during cold preservation in rats. Chin Med J 124:574–580

    CAS  PubMed  Google Scholar 

  34. Masuda T, Sato K, Noda C, Ikeda KM, Matsunaga A, Ogura MN, Shimizu K, Nagasawa H, Matsuyama N, Izumi T (2003) Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion. Crit Care Med 31:1987–1992

    CAS  PubMed  Google Scholar 

  35. Niknahad H, Jamshidzadeh A, Heidari R, Zarei M, Ommati MM (2017) Ammonia-induced mitochondrial dysfunction and energy metabolism disturbances in isolated brain and liver mitochondria, and the effect of taurine administration: relevance to hepatic encephalopathy treatment. Clin Exp Hepatol 3:141–151

    PubMed  PubMed Central  Google Scholar 

  36. Pardridge WM, Connor JD, Crawford IL (1975) Permeability changes in the blood-brain barrier: causes and consequences. CRC Crit Rev Toxicol 3:159–199

    CAS  PubMed  Google Scholar 

  37. Rama Rao KV, Verkman AS, Curtis KM, Norenberg MD (2014) Aquaporin-4 deletion in mice reduces encephalopathy and brain edema in experimental acute liver failure. Neurobiol Dis 63:222–228

    CAS  PubMed  Google Scholar 

  38. Scott TR, Kronsten VT, Hughes RD, Shawcross DL (2013) Pathophysiology of cerebral oedema in acute liver failure. World J Gastroenterol 19:9240–9255

    PubMed  PubMed Central  Google Scholar 

  39. Turner PV, Brabb T, Pekow C, Vasbinder MA (2011) Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci 50:600–613

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Xu B, Li KP, Shen F, Xiao HQ, Cai WS, Li JL, Liu QC, Jia L (2013) Ulinastatin reduces cancer recurrence after resection of hepatic metastases from colon cancer by inhibiting MMP-9 activation via the antifibrinolytic pathway. Biomed Res Int 2013:437950

    PubMed  PubMed Central  Google Scholar 

  41. Zhao Y, Cai H, Zhou P, Lin S, Pan Y, Liang X (2019) Protective effect of ulinastatin on hepatic ischemia reperfusion injury through autophagy activation in Chang liver cells. J Cell Biochem 120:14960–14970

    CAS  PubMed  Google Scholar 

  42. Zhou LW, Wang YL, Yan XT, He XH (2008) Urinary trypsin inhibitor treatment ameliorates acute lung and liver injury resulting from sepsis in a rat model. Saudi Med J 29:368–373

    PubMed  Google Scholar 

  43. Zhou J, Lian J, Li HX, Hong GL, Zhao GJ, Zhi SC, Qiu QM, Li MF, Lu ZQ (2016) Mechanism research and effect of ulinastatin in the brain tissue injury of acute hydrogen sulfide intoxicated rats. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 34:166–172

    CAS  PubMed  Google Scholar 

Download references

Funding

This work did not receive funding from any organizations.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to research design, conception, data collection and analysis interpretation and shared in the critically revised process of the manuscript. All authors have approved the final manuscript version, submitted for journal publication and agree to be accountable for research aspects.

Corresponding author

Correspondence to Rehab E. Abo El gheit.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Key points

• Targeting AQP4 might be an appropriate focal point to combat brain edema in fulminant ALF.

• ULI neuroprotective effects with improved neurological outcome could be designed as a novel mechanism-based therapeutic modality to control brain edema.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abo El gheit, R.E., Atef, M.M., Badawi, G.A. et al. Role of serine protease inhibitor, ulinastatin, in rat model of hepatic encephalopathy: aquaporin 4 molecular targeting and therapeutic implication. J Physiol Biochem 76, 573–586 (2020). https://doi.org/10.1007/s13105-020-00762-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13105-020-00762-0

Keywords

Navigation